LIAS and neoplasm: Furthermore, the anti-tumor effect of the CTX-Onc conjugate is greater than that of the CTX-based conjugate (ClTx-LS) reported by Xiang et al in vivo, which had an inhibition ratio of ~34% compared that of the saline group, at 5 mg/kg (38).